Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Neuroblastoma
100%
MYCN Amplification
100%
Chromosome 11q
100%
Checkpoint Kinase 1 (CHK1)
100%
Loss Amplification
100%
Tumor
20%
Isogenic
20%
Clinical High Risk
20%
Overall Survival Rate
20%
Drug Combination
20%
Loss of Heterozygosity
20%
Putative Drug Targets
20%
Therapeutic Approaches
20%
DNA Repair
20%
Chromosomal Aberrations
20%
Novel Therapeutic Targets
20%
Patient Outcomes
20%
Preclinical Development
20%
High-throughput Screening
20%
Multimodal Therapeutics
20%
Potential Power
20%
System Throughput
20%
Replication Stress Response
20%
Extracranial Solid Tumor
20%
Therapeutic Vulnerability
20%
Stress Response Pathways
20%
Biochemistry, Genetics and Molecular Biology
Chromosome 11q
100%
Kinase
100%
Phosphotransferase
100%
Synthetic Lethality
100%
Overall Survival
33%
DNA Repair
33%
Preclinical Study
33%
Survival Rate
33%
Chromosomal Aberration
33%
High Throughput Screening
33%
Medicine and Dentistry
Ganglioneuroblastoma
100%
Checkpoint Kinase 1
100%
Lethality
100%
Chromosome 11q
100%
Solid Malignant Neoplasm
20%
Biological Marker
20%
Survival Rate
20%
Overall Survival
20%
DNA Repair
20%
Tumor
20%
Chromosome Aberration
20%
High Throughput Screening
20%
Therapeutic Target
20%
Neuroscience
Neuroblastoma
100%
Chromosome 11q
100%
Checkpoint Kinase 1
100%
DNA Repair
20%
Biological Marker
20%